The possible difference in associations of IGF-I and IGFBP-3 and risk by menopausal status suggests that high levels of IGF-I and/or low levels of IGFBP-3 may be important in breast cancer development in younger, but not older, women. The gene discussed is IGF1; the disease is breast cancer.